AU3446200A - Susceptibility to psoriasis - Google Patents

Susceptibility to psoriasis

Info

Publication number
AU3446200A
AU3446200A AU34462/00A AU3446200A AU3446200A AU 3446200 A AU3446200 A AU 3446200A AU 34462/00 A AU34462/00 A AU 34462/00A AU 3446200 A AU3446200 A AU 3446200A AU 3446200 A AU3446200 A AU 3446200A
Authority
AU
Australia
Prior art keywords
psoriasis
susceptibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34462/00A
Other languages
English (en)
Inventor
Jonathan Nicholas William Noel Barker
Richard Charles Trembath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
University of Leicester
Original Assignee
Kings College London
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London, University of Leicester filed Critical Kings College London
Publication of AU3446200A publication Critical patent/AU3446200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/205—Scaling palpular diseases, e.g. psoriasis, pytiriasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34462/00A 1999-03-26 2000-03-27 Susceptibility to psoriasis Abandoned AU3446200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906993.2A GB9906993D0 (en) 1999-03-26 1999-03-26 Psoriasis
GB9906993 1999-03-26
PCT/GB2000/001152 WO2000058506A2 (fr) 1999-03-26 2000-03-27 Depistage d'une predisposition au psoriasis

Publications (1)

Publication Number Publication Date
AU3446200A true AU3446200A (en) 2000-10-16

Family

ID=10850413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34462/00A Abandoned AU3446200A (en) 1999-03-26 2000-03-27 Susceptibility to psoriasis

Country Status (6)

Country Link
EP (1) EP1144678A2 (fr)
JP (1) JP2002539844A (fr)
AU (1) AU3446200A (fr)
CA (1) CA2329261A1 (fr)
GB (1) GB9906993D0 (fr)
WO (1) WO2000058506A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1731201A (en) * 1999-12-06 2001-06-18 Hidetoshi Inoko Method of examining vulgar psoriasis
GB0004312D0 (en) * 2000-02-23 2000-04-12 Oxagen Limited Test and model for inflammatory disease
AU2085502A (en) * 2000-11-30 2002-06-11 Molecular Skincare Ltd Diagnosis and treatment of disease
FR2853910B1 (fr) * 2003-04-16 2007-08-24 Galderma Res & Dev Genes du psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761363B1 (fr) * 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
FR2761362B1 (fr) * 1997-03-28 1999-05-21 Oreal Polypeptide purifie de l'epiderme et son utilisation

Also Published As

Publication number Publication date
CA2329261A1 (fr) 2000-10-05
JP2002539844A (ja) 2002-11-26
EP1144678A2 (fr) 2001-10-17
WO2000058506A2 (fr) 2000-10-05
GB9906993D0 (en) 1999-05-19
WO2000058506A3 (fr) 2001-08-16

Similar Documents

Publication Publication Date Title
AU5593800A (en) Decision-analytic approach to human-computer interactions
AU5024000A (en) Moru/be multilayers
AU6172600A (en) Improvements relating to security
AU4431000A (en) Novel use
AU1784301A (en) Topical skin composition
AU4278699A (en) Improvements to pushchairs
GB9918760D0 (en) Topical treatment
AU5691800A (en) Structure
AU2201501A (en) Structure
AU3446200A (en) Susceptibility to psoriasis
GB0025524D0 (en) Improvements relating to screenboxes
AU6212500A (en) Serial data to parallel data converter
AU5549100A (en) Wheel structure
AU4808199A (en) Improvements to edging
AU5873300A (en) Process to prepare exemestane
AU6562700A (en) Granulates to be strewn
AU6711500A (en) Dressing
GB9901886D0 (en) Improvements relating to hinges
AU2175399A (en) Improvements relating to cooling devices
AU3061500A (en) Wheels
AU3496000A (en) Cross arm for utility poles
AU4834800A (en) Visual calculator
AU2226599A (en) Methods to identify myelostimulants
AUPP851699A0 (en) Utility pole
AUPQ363799A0 (en) Utility pole

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase